Nuclear scare to fuel anti-radiation drug sales? PTx buys ex-Sanofi drug just in case
Partner Therapeutics (PTx), a Boston startup formed last week by a pair of Merrimack and Seragon executives, has made its first move: it’s acquired …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
